Cargando…

Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy

Peroxisome-proliferator-activated receptors (PPARs) are nuclear hormone receptors including PPARα, PPARδ and PPARγ, which play an important role in regulating cancer cell proliferation, survival, apoptosis, and tumor growth. Activation of PPARs by endogenous or synthetic compounds regulates tumor pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gou, Qian, Gong, Xin, Jin, Jianhua, Shi, Juanjuan, Hou, Yongzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601172/
https://www.ncbi.nlm.nih.gov/pubmed/28948004
http://dx.doi.org/10.18632/oncotarget.19610
_version_ 1783264342090711040
author Gou, Qian
Gong, Xin
Jin, Jianhua
Shi, Juanjuan
Hou, Yongzhong
author_facet Gou, Qian
Gong, Xin
Jin, Jianhua
Shi, Juanjuan
Hou, Yongzhong
author_sort Gou, Qian
collection PubMed
description Peroxisome-proliferator-activated receptors (PPARs) are nuclear hormone receptors including PPARα, PPARδ and PPARγ, which play an important role in regulating cancer cell proliferation, survival, apoptosis, and tumor growth. Activation of PPARs by endogenous or synthetic compounds regulates tumor progression in various tissues. Although each PPAR isotype suppresses or promotes tumor development depending on the specific tissues or ligands, the mechanism is still unclear. In this review, we summarized the regulative mechanism of PPARs on cancer progression.
format Online
Article
Text
id pubmed-5601172
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-56011722017-09-25 Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy Gou, Qian Gong, Xin Jin, Jianhua Shi, Juanjuan Hou, Yongzhong Oncotarget Review Peroxisome-proliferator-activated receptors (PPARs) are nuclear hormone receptors including PPARα, PPARδ and PPARγ, which play an important role in regulating cancer cell proliferation, survival, apoptosis, and tumor growth. Activation of PPARs by endogenous or synthetic compounds regulates tumor progression in various tissues. Although each PPAR isotype suppresses or promotes tumor development depending on the specific tissues or ligands, the mechanism is still unclear. In this review, we summarized the regulative mechanism of PPARs on cancer progression. Impact Journals LLC 2017-07-27 /pmc/articles/PMC5601172/ /pubmed/28948004 http://dx.doi.org/10.18632/oncotarget.19610 Text en Copyright: © 2017 Gou et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Review
Gou, Qian
Gong, Xin
Jin, Jianhua
Shi, Juanjuan
Hou, Yongzhong
Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy
title Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy
title_full Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy
title_fullStr Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy
title_full_unstemmed Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy
title_short Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy
title_sort peroxisome proliferator-activated receptors (ppars) are potential drug targets for cancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601172/
https://www.ncbi.nlm.nih.gov/pubmed/28948004
http://dx.doi.org/10.18632/oncotarget.19610
work_keys_str_mv AT gouqian peroxisomeproliferatoractivatedreceptorspparsarepotentialdrugtargetsforcancertherapy
AT gongxin peroxisomeproliferatoractivatedreceptorspparsarepotentialdrugtargetsforcancertherapy
AT jinjianhua peroxisomeproliferatoractivatedreceptorspparsarepotentialdrugtargetsforcancertherapy
AT shijuanjuan peroxisomeproliferatoractivatedreceptorspparsarepotentialdrugtargetsforcancertherapy
AT houyongzhong peroxisomeproliferatoractivatedreceptorspparsarepotentialdrugtargetsforcancertherapy